Olaparib 150mg
Introduction
Olaparib is a targeted oncology medicine used in the treatment of certain cancers under specific clinical conditions. For international pharmaceutical distributors, licensed importers, hospital procurement departments, and authorized medicine wholesalers, sourcing Olaparib requires careful attention to product specifications, manufacturer information, quality documentation, and destination-country regulations.
India is an established pharmaceutical sourcing destination, offering international buyers access to a broad range of pharmaceutical products through manufacturers, suppliers, and exporters. However, selecting an appropriate supplier involves more than comparing prices. Buyers must verify the exact product, its manufacturing source, available documentation, and eligibility for import into the intended market.
Dolphin Pharmaceuticals, based in Surat, Gujarat, India, provides a pharmaceutical sourcing contact for international business enquiries. Buyers interested in Olaparib 150 mg can contact the company to enquire about product availability, manufacturer details, commercial terms, and applicable export requirements. Any proposed supply remains subject to confirmation of the specific product and the regulations governing the destination market.
This guide explains what international pharmaceutical buyers should consider when evaluating an Olaparib 150 mg exporter from India and how to approach oncology medicine procurement in a structured, transparent manner.
Key Highlights
- Product focus: Olaparib 150 mg for authorized pharmaceutical procurement.
- Therapeutic category: Targeted oncology medicine.
- Potential buyers: Licensed pharmaceutical importers, wholesalers, distributors, and eligible institutional procurement teams.
- Supplier evaluation: Verify product identity, actual manufacturer, quality documentation, and business credentials.
- Regulatory compliance: Confirm export and destination-country import requirements before shipment.
- Storage and logistics: Follow the specific product label and manufacturer instructions.
- Commercial planning: Compare pricing, quantity, shelf life, documentation, and delivery terms.
- Supplier enquiry: Contact Dolphin Pharmaceuticals to discuss the required product and potential sourcing arrangements.
Understanding Olaparib 150 mg
Olaparib belongs to a class of medicines known as PARP inhibitors. It works by interfering with certain mechanisms that cancer cells use to repair damaged DNA. It is used for selected cancer indications under specific clinical criteria.
The appropriate use of Olaparib depends on the cancer type, relevant molecular or genetic characteristics, previous treatments, and the applicable prescribing guidance. It is a prescription medicine and should be used only under the supervision of qualified healthcare professionals.
For pharmaceutical procurement, buyers should understand that a medicine's therapeutic category alone does not establish its suitability for a particular patient or indication. Product identity, approved indications, and destination-market authorization must be verified independently.
Product Details Buyers Should Confirm
- Generic name: Olaparib.
- Strength: 150 mg.
- Dosage form: Confirm whether the offered product is a tablet and verify the precise formulation.
- Therapeutic category: Targeted oncology medicine.
- Manufacturer: Confirm the actual manufacturer and manufacturing site.
- Packaging: Verify pack size, presentation, and labeling.
- Storage conditions: Follow the product-specific approved labeling.
- Regulatory status: Confirm registration or other applicable authorization in the destination country.
- Documentation: Request the quality and regulatory documents required for the particular product and transaction.
These details should be confirmed before a quotation is accepted or a purchase order is finalized.
Why Choose a Reliable Olaparib 150 mg Exporter from India?
A suitable pharmaceutical exporter should be able to communicate clearly about the product being offered and the requirements involved in supplying it internationally.
1. Product Identification and Transparency
Product identification is the starting point for reliable pharmaceutical procurement. Buyers should ensure that the generic name, strength, dosage form, manufacturer, packaging, and labeling match the requested specifications.
When reviewing an offer for Olaparib 150 mg, confirm that all product details are consistent across the quotation, product documentation, and proposed shipment.
2. Manufacturer Verification
An exporter is not necessarily the manufacturer of every medicine it supplies. Some pharmaceutical businesses export products manufactured by other companies.
International buyers should establish whether the proposed supplier is the manufacturer, an authorized distributor, or an exporter sourcing the product from another manufacturer.
Confirming the actual manufacturing source helps buyers conduct appropriate supplier assessments and meet their internal procurement requirements.
3. Quality Documentation
Quality documentation is an important part of oncology medicine sourcing. Buyers should request the documents applicable to the product, manufacturer, and destination market.
Depending on the transaction, these may include product specifications, batch-related documentation, a Certificate of Analysis, and relevant manufacturing or regulatory records.
Documents should correspond to the actual product being offered. Buyers should resolve discrepancies in product names, strengths, manufacturers, batch information, or other material details before proceeding.
4. Clear Commercial Communication
A professional sourcing process should include clear information about pricing, minimum order quantities where applicable, quotation validity, payment terms, estimated lead time, and shipping arrangements.
Buyers should request written confirmation of the agreed product specifications and commercial conditions to reduce the risk of misunderstandings.
5. Export and Import Coordination
International pharmaceutical transactions involve requirements in both the exporting and importing countries. Buyers should confirm which documents the supplier can provide and which approvals or permits must be arranged by the importer.
A supplier's ability to export a medicine from India does not automatically mean that the product is approved for importation or sale in every destination market.
Dolphin Pharmaceuticals: An Indian Pharmaceutical Sourcing Contact
Dolphin Pharmaceuticals, based in Surat, Gujarat, India, can be approached by international pharmaceutical buyers to discuss product-specific sourcing requirements.
For businesses searching for an Olaparib 150 mg exporter from India, the appropriate first step is to submit an enquiry containing the exact product specifications and destination country.
Before considering a proposed supply arrangement, buyers should request confirmation of:
- Current availability of Olaparib 150 mg.
- Exact dosage form and product presentation.
- Brand name, if applicable.
- Actual manufacturer and manufacturing site.
- Available product and batch documentation.
- Minimum order quantity and quotation terms.
- Remaining shelf life and proposed delivery timeline.
- Export documentation and shipping arrangements.
- Eligibility for import into the destination market.
These details must be confirmed directly. The existence of an enquiry or a general oncology product category does not establish that a specific Olaparib product is in stock, approved for a particular market, or available for export.
How International Buyers Can Evaluate an Olaparib Supplier
A structured supplier assessment can help pharmaceutical businesses make more informed purchasing decisions.
Step 1: Define the Product Requirement
Prepare a clear product specification before requesting a quotation.
Include the generic name, strength, dosage form, preferred brand where applicable, required quantity, packaging requirements, and destination country.
If a specific manufacturer is required, state this in the enquiry so that the supplier can assess the request accurately.
Step 2: Review Supplier Credentials
Evaluate the supplier's legal business details, role in the pharmaceutical supply chain, relevant authorizations, and ability to support the proposed transaction.
Where applicable, verify the credentials of the actual manufacturer and other parties involved in the supply chain.
Step 3: Request Product Documentation
Ask for the documents required by your organization and the relevant regulatory authorities. Ensure that the documentation matches the precise product being offered.
Do not assume that a generic quality certificate automatically proves the quality, authenticity, or regulatory eligibility of every product supplied by a company.
Step 4: Confirm Product and Market Authorization
Verify whether the specific Olaparib product is registered or otherwise authorized for the intended market. Determine whether the proposed importer and distribution channel meet local requirements.
Complete these checks before confirming an order or arranging shipment.
Step 5: Compare Complete Quotations
Compare offers using consistent product specifications and commercial conditions.
Consider the unit price, order quantity, packaging, remaining shelf life, documentation, shipping expenses, insurance where applicable, and estimated delivery timeline.
A lower quotation is not necessarily the best option if important product or regulatory requirements remain unresolved.
Step 6: Confirm Supply and Delivery Terms
Before placing an order, obtain written confirmation of the agreed product, manufacturer, quantity, packaging, delivery conditions, and documentation responsibilities.
For repeat orders, also discuss availability planning, lead times, and procedures for addressing shortages or discrepancies.
Quality and Regulatory Documentation for Olaparib 150 mg
Documentation requirements vary according to the product, manufacturer, destination country, and nature of the transaction. Buyers should establish a product-specific checklist before purchasing.
Product and Manufacturer Documents
Depending on the applicable requirements, buyers may need:
- Product specifications and composition details.
- Manufacturer name and manufacturing-site information.
- Product labeling and packaging information.
- Applicable manufacturing or quality certificates.
- Product registration or authorization records.
- Evidence supporting the product's identity and origin.
Batch-Related Documents
Where applicable and available, request:
- Batch number and expiry details.
- Certificate of Analysis for the relevant batch.
- Relevant quality-release documentation.
- Information required for product traceability.
The documents should be consistent with the batch and product actually offered.
Commercial and Shipping Documents
Depending on the transaction, the required documents may include:
- Proforma invoice and commercial invoice.
- Packing list.
- Purchase order and agreed commercial terms.
- Shipping documentation.
- Export or import permits where required.
- Other certificates requested by the relevant authorities.
Not every document applies to every shipment. The exporter and importer should confirm the applicable requirements before dispatch.
Pharmaceutical Export and Import Requirements
Exporting oncology medicines requires attention to the regulations governing the product and the countries involved in the transaction.
For shipments originating in India, the parties should determine which export-related requirements apply to the particular medicine, supplier, and transaction. The importing organization must also confirm the requirements in the destination country.
International buyers should verify:
- Whether the product can legally be exported under the proposed arrangement.
- Whether the manufacturer and supplier hold the necessary authorizations.
- Whether the product is registered or otherwise approved in the destination market.
- Whether an import permit or other authorization is required.
- Whether the importing organization is appropriately licensed.
- Whether labeling, packaging, and accompanying documents meet local requirements.
- Whether customs and other shipment procedures have been addressed.
Important: Approval in one country does not automatically establish approval in another. Buyers should obtain current, product-specific guidance from the relevant regulatory authorities before committing to an order.
Storage, Packaging, and Transportation
Olaparib products must be stored and transported according to the requirements stated in the applicable product labeling and manufacturer documentation.
International buyers should confirm the following before shipment:
- Storage conditions: Obtain the specific storage instructions for the offered product.
- Packaging integrity: Ensure that packaging is suitable for the product and remains intact during transport.
- Shelf life: Agree on minimum remaining shelf life at dispatch or arrival, where required.
- Transit time: Account for shipping, customs clearance, and local distribution.
- Handling requirements: Communicate any product-specific precautions to the logistics provider and receiving organization.
- Traceability: Maintain relevant records for the product and shipment.
Storage conditions should never be assumed based solely on the general therapeutic category. Follow the requirements for the exact product being supplied.
How to Request a Quotation for Olaparib 150 mg
A detailed enquiry helps the supplier assess whether the requested product can be sourced and what commercial and documentation requirements may apply.
When contacting Dolphin Pharmaceuticals, include:
- Product name: Olaparib.
- Strength: 150 mg.
- Dosage form: The required formulation.
- Quantity: The intended order quantity.
- Destination country: The country where the medicine will be imported.
- Manufacturer preference: If applicable.
- Documentation requirements: Any known product or regulatory documents required.
- Delivery expectations: Preferred delivery terms and timing.
- Importer details: Information relevant to verifying the intended commercial transaction and applicable authorizations.
Ask the supplier to confirm availability, manufacturer information, quotation validity, minimum order quantity, shelf life, documentation, and export eligibility.
A quotation should be reviewed against the buyer's product specifications and regulatory requirements before an order is approved.
Frequently Asked Questions
1. What is Olaparib 150 mg?
Olaparib is a PARP inhibitor used for selected cancer indications under specific clinical conditions. It is a prescription medicine, and its use must be determined by qualified healthcare professionals.
2. How can I find an Olaparib 150 mg exporter from India?
Identify potential suppliers and evaluate their business credentials, manufacturer transparency, product documentation, commercial terms, and ability to support the proposed export transaction. Confirm the product's eligibility for import into the destination country before placing an order.
3. Does Dolphin Pharmaceuticals currently have Olaparib 150 mg available?
Current availability must be confirmed directly with Dolphin Pharmaceuticals. Buyers should provide the required dosage form, quantity, destination country, and any manufacturer preference so that the enquiry can be assessed.
4. What documents should I request from an Olaparib supplier?
Depending on the product and destination requirements, buyers may need product specifications, manufacturer details, batch documentation, a Certificate of Analysis, applicable regulatory records, and commercial shipping documents.
5. Can Olaparib 150 mg be exported to any country?
Not automatically. Export and import eligibility depends on the product, the parties involved, and the applicable regulations in both the exporting and destination countries. Buyers must verify the requirements for the specific transaction.
6. What should I check before accepting a quotation?
Confirm the exact product, strength, dosage form, manufacturer, packaging, quantity, price, remaining shelf life, documentation, shipping arrangements, and regulatory eligibility.
7. Is the exporter always the manufacturer?
No. A pharmaceutical exporter may manufacture the product itself or supply products manufactured by another company. Buyers should verify the actual manufacturer of the medicine being offered.
8. How can I plan repeat orders?
Discuss expected demand, order lead times, product availability, minimum order quantities, remaining shelf life, and documentation requirements. Repeat supply should be planned around confirmed availability and applicable regulatory approvals rather than assumptions.
Conclusion
Choosing an Olaparib 150 mg exporter from India requires a careful review of product specifications, manufacturer details, quality documentation, commercial terms, storage requirements, and destination-market regulations.
For international pharmaceutical importers, wholesalers, distributors, and eligible institutional buyers, a transparent procurement process begins with an accurate product enquiry and verification of the proposed supply arrangement.
Dolphin Pharmaceuticals, based in Surat, Gujarat, India, can be contacted to discuss Olaparib 150 mg sourcing requirements. Buyers should confirm current availability, the actual manufacturer, applicable documentation, quotation terms, and export eligibility directly with the company and the relevant authorities before placing an order.
Planning to source Olaparib 150 mg for your pharmaceutical business? Prepare your product specifications, required quantity, destination country, and documentation requirements, then contact Dolphin Pharmaceuticals to enquire about a potential supply arrangement. Request written confirmation of product details and regulatory eligibility before finalizing your purchase.
Disclaimer: This article is intended for pharmaceutical procurement and general informational purposes only. It does not constitute medical advice or confirm product availability, registration, approval, or export eligibility. Olaparib should be prescribed and used under qualified medical supervision.
My Company Name - Dolphin Pharmaceuticals
My Website - https://www.dolphinpharma.in/